Post-Market Studies on Generic Drug Safety: What Happens After Approval
Generic drugs are approved without new safety trials, making post-market surveillance critical. Learn how the FDA tracks adverse events, quality issues, and real-world risks after approval - and what patients and providers need to know.
Read More
